Bayesian Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-5,434
| Closed | -$219K | – | 795 |
|
|
2018
Q4 | $219K | Buy |
+5,434
| New | +$219K | 0.04% | 497 |
|
|
2018
Q1 | – | Sell |
-5,231
| Closed | -$279K | – | 859 |
|
|
2017
Q4 | $279K | Buy |
+5,231
| New | +$279K | 0.06% | 430 |
|
|
2016
Q4 | – | Sell |
-3,032
| Closed | -$212K | – | 730 |
|
|
2016
Q3 | $212K | Buy |
+3,032
| New | +$212K | 0.14% | 273 |
|